Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 1
2014 4
2015 3
2016 2
2017 2
2019 1
2020 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Drug Development for Cystic Kidney Diseases.
Fedeles S, Perrone RD. Fedeles S, et al. Clin J Am Soc Nephrol. 2022 Oct;17(10):1549-1550. doi: 10.2215/CJN.04910422. Epub 2022 Aug 23. Clin J Am Soc Nephrol. 2022. PMID: 35998972 Free PMC article. No abstract available.
Cell polarity and cystic kidney disease.
Fedeles S, Gallagher AR. Fedeles S, et al. Pediatr Nephrol. 2013 Aug;28(8):1161-72. doi: 10.1007/s00467-012-2337-z. Epub 2012 Nov 16. Pediatr Nephrol. 2013. PMID: 23161205 Review.
XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
Krappitz M, Bhardwaj R, Dong K, Staudner T, Yilmaz DE, Pioppini C, Westergerling P, Ruemmele D, Hollmann T, Nguyen TA, Cai Y, Gallagher AR, Somlo S, Fedeles S. Krappitz M, et al. Among authors: fedeles s. J Am Soc Nephrol. 2023 Jan 1;34(1):110-121. doi: 10.1681/ASN.2021091180. Epub 2022 Oct 21. J Am Soc Nephrol. 2023. PMID: 36270750 Free PMC article.
Is it Time to Fold the Cysts Away?
Krappitz M, Gallagher AR, Fedeles S. Krappitz M, et al. Among authors: fedeles s. Trends Mol Med. 2016 Dec;22(12):997-999. doi: 10.1016/j.molmed.2016.10.001. Epub 2016 Oct 25. Trends Mol Med. 2016. PMID: 27793600
A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress.
Fedeles BI, Bhardwaj R, Ishikawa Y, Khumsubdee S, Krappitz M, Gubina N, Volpe I, Andrade DC, Westergerling P, Staudner T, Campolo J, Liu SS, Dong K, Cai Y, Rehman M, Gallagher AR, Ruchirawat S, Croy RG, Essigmann JM, Fedeles SV, Somlo S. Fedeles BI, et al. Among authors: fedeles sv. Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2317344121. doi: 10.1073/pnas.2317344121. Epub 2024 Jan 19. Proc Natl Acad Sci U S A. 2024. PMID: 38241440 Free PMC article.
Polycystic Kidney Disease Drug Development: A Conference Report.
Liebau MC, Mekahli D, Perrone R, Soyfer B, Fedeles S. Liebau MC, et al. Among authors: fedeles s. Kidney Med. 2022 Dec 27;5(3):100596. doi: 10.1016/j.xkme.2022.100596. eCollection 2023 Mar. Kidney Med. 2022. PMID: 36698747 Free PMC article.
Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W, Dong K, Choi J, Punia S, Fedeles SV, Choi M, Gallagher AR, Huang EB, Gulati A, Knight J, Mane S, Tahvanainen E, Tahvanainen P, Sanna-Cherchi S, Lifton RP, Watnick T, Pei YP, Torres VE, Somlo S. Besse W, et al. Among authors: fedeles sv. J Clin Invest. 2017 May 1;127(5):1772-1785. doi: 10.1172/JCI90129. Epub 2017 Apr 4. J Clin Invest. 2017. PMID: 28375157 Free PMC article.
20 results